MétaCan
Menu
Back to cohort
Record W4296515329 · doi:10.1136/gutjnl-2022-basl.7

O07 Results of the first national audit of PBC management reveal significant variation in care delivery across the UK

2022· article· en· W4296515329 on OpenAlexaff
Rachel J. Smith, Nadir Abbas, Steve Flack, Andrew D. Yeoman, Douglas Thorburn, Richard Aspinall, Rebecca L. Jones, Joanna Leithead, Conor Braniff, Michael A. Heneghan, Collette Thain, Thomas J. Mitchell, Robert Mitchell-Thain, David Jones, Palak Trivedi, George Mells, Laith Alrubaiy

Bibliographic record

VenueAbstracts · 2022
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsInstitute of Infection and Immunity
Fundersnot available
KeywordsAuditMedicineBespokeUrsodeoxycholic acidInternal medicinePopulationFamily medicineEmergency medicineEnvironmental health

Abstract

fetched live from OpenAlex

The UK-PBC audit is a collaborative project sanctioned by the British Association for the Study of the Liver (BASL), the British Society of Gastroenterology (BSG), UK-PBC and the PBC Foundation, established to benchmark current management of primary biliary cholangitis (PBC) in the UK National Health Service (NHS) against the BSG audit standards published in 2018. All NHS trusts and health boards were invited to participate in the audit. From January 2021 to April 2022, participating centres collected retrospective patient data using a bespoke audit tool on the REDCap (Research Electronic Data Capture) platform. Data were collected about 8937 patients from 122 NHS trusts and health boards across the UK. Most of the audited population were female (88.9%) and aged 50 to 79 (78.0%). In total, 7864 of 8937 (88.0%) patients received ursodeoxycholic acid (UDCA) as first-line therapy. The dose of UDCA was sub-optimal (less than 13 mg/kg/day) in 30.6% of cases, with more patients under-dosed in Operational Delivery Network (ODN) spokes (33.8%) compared to hubs (25.7%). Overall, 2618 patients were identified as high-risk. Of these, only 1293 (49.4%) received second-line treatment (SLT). The proportion of high-risk patients on SLT was greater in ODN hubs (70.5%) compared to spokes (26.5%). There was no significant variation in the prescribing of SLT in England (48.5%) and Wales (50.0%) compared to Scotland (53.7%). 259 patients below the age of 70 had evidence of end-stage liver disease (ESLD); 166 (64.1%) were discussed with a transplant centre. A greater number of ESLD patients were discussed with transplant centres in England (66.2%) and Scotland (65.6%) compared to Wales (18.0%). In England, a greater proportion of ESLD patients had been discussed with transplant centres in ODN hubs (76.1%) compared to spokes (56.1%). There was also regional variation, with a greater proportion of ESLD patients discussed in North East England (100%) compared to the North West (30.4%). We have demonstrated significant variation in key aspects of PBC management across the UK. Shortfalls in the referral of high-risk patients for SLT, and ESLD patients for liver transplantation, mean that eligible patients are left without effective treatment. Possible solutions, such as the development of a PBC care bundle, will address these critical deficits, and its dissemination throughout the UK will be vital in improving the delivery of PBC-related healthcare.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.025
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.066
Threshold uncertainty score0.131

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.025
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.003
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0000.002
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.256
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAbstractsSame topicLiver Diseases and ImmunityFrench-language works237,207